Suchergebnisse - "Xiong, Yanlu"

PubPharm (47)

1

Early postoperative endoscopy for predicting anastomotic leakage after minimally invasive esophagectomy : A large-volume retrospective study

enthalten in: Surgery | 2024

von Ma, S. | Zhu, J. | Xue, M. | +8

2

A gene-based score for the risk stratification of stage IA lung adenocarcinoma

enthalten in: Respiratory research | 2024

von Xiong, Y. | Ma, Y. | Liu, K. | +11

3

Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction

enthalten in: Aging | 2023

von Zuo, B. | Wang, L. | Li, X. | +13

4

Circulating tumor DNA minimal residual disease in clinical practice of non-small cell lung cancer

enthalten in: Expert review of molecular diagnostics | 2023

von Xia, J. | Zhang, J. | Xiong, Y. | +4

5

Identification of highly proliferative tumor subgroups in lung adenocarcinoma, feature gene set and application

enthalten in: Europäisches Patentamt | 2023

von XIONG YANLU | ZHANG YANNING | LIANG JIAHE | +4

6

Clinical test-based diagnosis and treatment data evaluation system and evaluation method

enthalten in: Europäisches Patentamt | 2023

von LEI JIE | ZHANG NA | EMOTO TAKESHI | +2

7

Clinical test-based diagnosis and treatment data evaluation system and evaluation method

enthalten in: Europäisches Patentamt | 2023

von LEI JIE | ZHANG NA | EMOTO TAKESHI | +2

8

Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Qiao, T. | Zhao, J. | Xin, X. | +8

ErratumIn: Cancer Immunol Immunother. 2022 Dec 26;:. - PMID 36571598

9

Correction to : Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Qiao, T. | Zhao, J. | Xin, X. | +8

ErratumFor: Cancer Immunol Immunother. 2023 May;72(5):1169-1181. - PMID 36357599

10

Development and validation of a gene-based classification model for pN2 lung adenocarcinoma

enthalten in: Translational lung cancer research | 2023

von Zhu, J. | Wang, W. | Ma, Y. | +2

1
2
3
4
5
Nächster »
[5]